healthprotocol.wiki

stem-cell-transplant-allogeneic-mismatched-bortezomib

Outcomes

01
immune-gvhd-chronic-cumulative-incidence-at-1-year-percent-cohort-measured
1 evidence row
- dana-farber-investigators_2017_cohort_bortezomib-added-to-standard-gvhd-prevention-regimen-in-hla-mismatched-transplants